Controlled studies of antiparkinsonism agents in the treatment of drug-induced extrapyramidal sympttoms.
D000433:1-Propanol / Q000494:pharmacology; D000328:Adult; D001712:Biperiden / Q000008:administration & dosage / Q000494:pharmacology; D002986:Clinical Trials as Topic; D006236:Handwriting; D006801:Humans; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination; D010276:Parasympatholytics / Q000494:pharmacology*; D010300:Parkinson Disease / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010640:Phenothiazines; D010880:Piperidines / Q000494:pharmacology*; D011569:Psychiatric Status Rating Scales
D010276:Parasympatholytics; D010640:Phenothiazines; D010880:Piperidines; D001712:Biperiden; D000433:1-Propanol